Short answer

FIB-4 is a simple score that uses age, AST, ALT, and platelet count to estimate the chance of advanced liver fibrosis. It is used most often as a triage tool in chronic liver disease, especially metabolic dysfunction-associated steatotic liver disease / fatty liver disease, to help decide whether elastography, hepatitis workup, or specialist review is needed. It does not diagnose cirrhosis by itself.

How FIB-4 works

PieceWhy it matters
AgePart of the formula, so older adults can score higher even when disease is not advanced.
AST and ALTHelp show liver-cell injury patterns, though normal values do not exclude fibrosis.
Platelet countCan fall as liver fibrosis advances, but other conditions can lower platelets too.

What the score can and cannot do

Result patternWhat it usually meansTypical next step
Low FIB-4Advanced fibrosis is less likely.Routine follow-up and risk-factor management if the clinical picture fits.
Indeterminate FIB-4The score alone cannot sort risk well enough.Elastography or another noninvasive fibrosis test.
High FIB-4Advanced fibrosis is more concerning.Secondary testing and possible hepatology referral.

AASLD guidance and educational material commonly use 1.3 and 2.67 as important low- and high-risk thresholds in fatty liver risk assessment, with age caveats for younger and older adults. The exact cutoffs can vary by condition and clinical setting, so the score should never be read in isolation.

What usually comes next

  • Elastography if the score is indeterminate or high.
  • Hepatitis B and C testing if viral liver disease has not been excluded.
  • Alcohol, medication, and metabolic risk review if the liver pattern is unclear.
  • Liver biopsy only when the question still matters after noninvasive testing, or when a clinician needs a definitive stage or diagnosis.

Questions to ask

  • Was FIB-4 calculated from current AST, ALT, platelet count, and age?
  • Is the result low, indeterminate, or high for my age and liver-risk context?
  • Should elastography, hepatitis testing, ultrasound, or repeat labs be done next?
  • Could acute illness, alcohol use, or another platelet problem distort the score?
  • Do I need liver specialist follow-up now, or can this be monitored in primary care?

What follow-up may include

  • Elastography or another noninvasive fibrosis test when FIB-4 is indeterminate or high.
  • Hepatitis B and C testing if viral liver disease has not been excluded.
  • Review of alcohol use, medications, metabolic risk, and recent illness that can shift AST, ALT, or platelets.
  • Repeat fibrosis scoring after the acute issue settles if the clinician thinks the first result was distorted.
  • Hepatology referral when the score and other liver findings keep pointing toward advanced fibrosis.

FAQ

What is FIB-4 used for?

FIB-4 uses age, AST, ALT, and platelets to estimate the chance of advanced liver fibrosis and decide whether more testing is needed.

What do low, indeterminate, and high FIB-4 results mean?

A low result usually suggests advanced fibrosis is unlikely, an indeterminate result needs another test, and a high result raises concern for further fibrosis assessment.

Can normal AST and ALT rule out fibrosis?

No. Normal liver enzymes do not exclude fibrosis, which is why simple scores and elastography are used together.

Why does age matter so much in FIB-4?

Age is part of the formula, so older adults can score higher even when disease is not advanced. AASLD notes age-related caveats, especially under 35 and over 65.

What test often comes after FIB-4?

Elastography is a common next step when the score is indeterminate or high because it measures liver stiffness more directly.

Can FIB-4 diagnose cirrhosis by itself?

No. It is a triage tool, not a biopsy replacement or a standalone cirrhosis diagnosis.

Bottom line: FIB-4 is most useful as a first-pass fibrosis screen. The score becomes actionable when it is paired with liver-risk context, repeat labs, and a next-step test when needed.